Tag: AstraZeneca’s

Posted on

AstraZeneca’s Severe Asthma Drug Positive in Phase III – Zacks.com


Wall Street Journal

AstraZeneca's Severe Asthma Drug Positive in Phase III
Zacks.com
These randomized, double-blind, parallel-group, placebo-controlled studies evaluated the safety and efficacy of benralizumab as an add-on therapy in the treatment of severe uncontrolled asthma with eosinophilic inflammation in patients aged 12 years …
AstraZeneca's Asthma Drug Shows Positive ResultsWall Street Journal
AstraZeneca set to go head to head against GSK with asthma drugFinancial Times
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
FierceBiotech –The Guardian –Philadelphia Business Journal
all 34 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca’s Asthma Drug Shows Positive Results – Wall Street Journal


Wall Street Journal

AstraZeneca's Asthma Drug Shows Positive Results
Wall Street Journal
Bing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by …
AstraZeneca set to go head to head against GSK with asthma drugFinancial Times
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
AstraZeneca's asthma biologic hits PhIII target, but still behind rivalsFierceBiotech
The Guardian –Philadelphia Business Journal –MarketWatch
all 31 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca’s patent on asthma drug invalidated by U.S. court – Business Insider


Business Insider

AstraZeneca's patent on asthma drug invalidated by U.S. court
Business Insider
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
AstraZeneca plc (ADR) Patent On Asthma Drug Declared Invalid By US CourtBidness ETC
AstraZeneca loses its US patent rights for asthma drug Pulmicort RespulesCITY A.M.

all 37 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca’s patent on asthma drug invalidated by US court – Reuters


Reuters

AstraZeneca's patent on asthma drug invalidated by US court
Reuters
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 7 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca’s patent on asthma drug invalidated by US court – Yahoo News


euronews

AstraZeneca's patent on asthma drug invalidated by US court
Yahoo News
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 2 news articles »

View full post on asthma – Google News